173 related articles for article (PubMed ID: 24410179)
21. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
Coghill DR; Rhodes SM; Matthews K
Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and subjective/physiological responses to emotional stimuli in the presence of emotion dysregulation in attention-deficit hyperactivity disorder.
Taskiran C; Karaismailoglu S; Cak Esen HT; Tuzun Z; Erdem A; Balkanci ZD; Dolgun AB; Cengel Kultur SE
J Clin Exp Neuropsychol; 2018 May; 40(4):389-404. PubMed ID: 28721740
[TBL] [Abstract][Full Text] [Related]
23. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
Pearson DA; Lane DM; Santos CW; Casat CD; Jerger SW; Loveland KA; Faria LP; Mansour R; Henderson JA; Payne CD; Roache JD; Lachar D; Cleveland LA
J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):686-98. PubMed ID: 15167085
[TBL] [Abstract][Full Text] [Related]
24. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
Pearson DA; Santos CW; Casat CD; Lane DM; Jerger SW; Roache JD; Loveland KA; Lachar D; Faria LP; Payne CD; Cleveland LA
J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):677-85. PubMed ID: 15167084
[TBL] [Abstract][Full Text] [Related]
25. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.
Zang YF; Jin Z; Weng XC; Zhang L; Zeng YW; Yang L; Wang YF; Seidman LJ; Faraone SV
Brain Dev; 2005 Dec; 27(8):544-50. PubMed ID: 15876503
[TBL] [Abstract][Full Text] [Related]
26. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
[TBL] [Abstract][Full Text] [Related]
27. Is autonomic nervous system function atypical in attention deficit hyperactivity disorder (ADHD)? A systematic review of the evidence.
Bellato A; Arora I; Hollis C; Groom MJ
Neurosci Biobehav Rev; 2020 Jan; 108():182-206. PubMed ID: 31722229
[TBL] [Abstract][Full Text] [Related]
28. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials.
Sawada M; Iida J; Ota T; Negoro H; Tanaka S; Sadamatsu M; Kishimoto T
Psychiatry Clin Neurosci; 2010 Oct; 64(5):491-8. PubMed ID: 20923428
[TBL] [Abstract][Full Text] [Related]
29. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder.
Bottelier MA; Schrantee A; Ferguson B; Tamminga HGH; Bouziane C; Kooij JJS; de Ruiter MB; Reneman L
Psychiatry Res Neuroimaging; 2017 Nov; 269():36-42. PubMed ID: 28938219
[TBL] [Abstract][Full Text] [Related]
30. Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
McCarthy S; Neubert A; Man KKC; Banaschewski T; Buitelaar J; Carucci S; Coghill D; Danckaerts M; Falissard B; Garas P; Häge A; Hollis C; Inglis S; Kovshoff H; Liddle E; Mechler K; Nagy P; Rosenthal E; Schlack R; Sonuga-Barke E; Zuddas A; Wong ICK
BMC Psychiatry; 2018 Oct; 18(1):327. PubMed ID: 30305167
[TBL] [Abstract][Full Text] [Related]
31. The effect of methylphenidate on very low frequency electroencephalography oscillations in adult ADHD.
Cooper RE; Skirrow C; Tye C; McLoughlin G; Rijsdijk F; Banaschweski T; Brandeis D; Kuntsi J; Asherson P
Brain Cogn; 2014 Apr; 86():82-9. PubMed ID: 24594658
[TBL] [Abstract][Full Text] [Related]
32. Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.
Wolff C; Alfred A; Lindermüller A; Rettig K; Mattejat F; Gerwe M; Slawik L; Schäuble B
Curr Med Res Opin; 2011; 27 Suppl 2():35-44. PubMed ID: 21787126
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
[TBL] [Abstract][Full Text] [Related]
34. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
[TBL] [Abstract][Full Text] [Related]
35. Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder.
Rosch KS; Fosco WD; Pelham WE; Waxmonsky JG; Bubnik MG; Hawk LW
J Abnorm Child Psychol; 2016 Feb; 44(2):309-21. PubMed ID: 25985978
[TBL] [Abstract][Full Text] [Related]
36. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study.
Galland BC; Tripp EG; Taylor BJ
J Sleep Res; 2010 Jun; 19(2):366-73. PubMed ID: 20050995
[TBL] [Abstract][Full Text] [Related]
37. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.
Cox DJ; Merkel RL; Penberthy JK; Kovatchev B; Hankin CS
J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):269-75. PubMed ID: 15076259
[TBL] [Abstract][Full Text] [Related]
38. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
39. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Psychol Psychiatry; 2016 May; 57(5):633-44. PubMed ID: 26748531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
